Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts.
Ontology highlight
ABSTRACT: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease lacking effective treatments. This is due, in part, to a complex and incompletely understood pathophysiology. To shed light, we conducted untargeted metabolomics on plasma from two independent cross-sectional ALS cohorts versus control participants to identify recurrent dysregulated metabolic pathways. Untargeted metabolomics was performed on plasma from two ALS cohorts (cohort 1, n = 125; cohort 2, n = 225) and healthy controls (cohort 1, n = 71; cohort 2, n = 104). Individual differential metabolites in ALS cases versus controls were assessed by Wilcoxon, adjusted logistic regression and partial least squares-discriminant analysis, while group lasso explored sub-pathway level differences. Adjustment parameters inclu
SUBMITTER: Goutman SA
PROVIDER: S-EPMC9762943 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA